Bodevet, Inc.

Part of Cellphire, Inc.

UEI
JWXLUQ1AJ7M1
CAGE
8C3U1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

FY2025 rankings

Its parent company, Cellphire, Inc., ranks:

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$211,699
FY2024 $0
FY2023 $759,102

Contract awards

Award Agency Obligated Awarded
Clinical trial in support of trauma indications for lyophilized canine blood products W81XWH20C0067 Defense Health Agency $2,540,073

Quick answers

Is Bodevet, Inc. registered in SAM.gov?

Bodevet, Inc.'s SAM.gov registration expired on May 18, 2024.

What is Bodevet, Inc.'s CAGE code?

Bodevet, Inc.'s CAGE code is 8C3U1, and its Unique Entity ID (UEI) is JWXLUQ1AJ7M1.

How much has Bodevet, Inc. received in federal contracts?

Federal contracts obligated $547,403 to Bodevet, Inc. in fiscal years 2023 through 2027.

How does Bodevet, Inc. rank among federal contractors?

Bodevet, Inc.'s parent company, Cellphire, Inc., ranked #58 in PSC AN and #95 at the Defense Health Agency in FY2025.

What is Bodevet, Inc.'s most recent federal award?

Bodevet, Inc.'s most recent federal contract award is Clinical trial in support of trauma indications for lyophilized canine blood products (W81XWH20C0067), from Defense Health Agency, on May 1, 2020.

On GovTribe

See Bodevet, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe